Exploring the ameliorative potential of Bacopa monnieri in acetic acid induced ulcerative colitis in mice

References

• Ahmad H, Kumar VL. 2018. Pharmacotherapy of ulcerative colitis – current status and emerging trends. J Basic Clin Physiol Pharmacol. 29(6):581–592. doi: 10.1515/jbcpp-2016-0014.
   PubMedGoogle Scholar
• Aranda CJ, Ocón B, Arredondo-Amador M, Suárez MD, Zarzuelo A, Chazin WJ, Martínez-Augustin O, Sánchez de Medina F. 2018. Calprotectin protects against experimental colonic inflammation in mice. Br J Pharmacol. 175(19):3797–3812. doi: 10.1111/bph.14449.
   PubMed Web of Science ®Google Scholar
• Axelrad JE, Roy A, Lawlor G, Korelitz B, Lichtiger S. 2016. Thiopurines and inflammatory bowel disease: current evidence and a historical perspective. World J Gastroenterol. 22(46):10103–10117. doi: 10.3748/wjg.v22.i46.10103.
   PubMed Web of Science ®Google Scholar
• Bravatà I, Fiorino G, Allocca M, Repici A, Danese S. 2015. New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease. Scand J Gastroenterol. 50(1):113–120. doi: 10.3109/00365521.2014.993700.
   PubMed Web of Science ®Google Scholar
• Chaparro M, Gisbert JP. 2016. Maintenance therapy options for ulcerative colitis. Expert Opin Pharmacother. 17(10):1339–1349. doi: 10.1080/14656566.2016.1187132.
   PubMed Web of Science ®Google Scholar
• Colombo BB, Fattori V, Guazelli CFS, Zaninelli TH, Carvalho TT, Ferraz CR, Bussmann AJC, Ruiz-Miyazawa KW, Baracat MM, Casagrande R, et al. 2018. Vinpocetine ameliorates acetic acid-induced colitis by inhibiting NF-κB activation in mice. Inflammation. 41(4):1276–1289. PMID: 29633103. doi: 10.1007/s10753-018-0776-9.
   PubMed Web of Science ®Google Scholar
• Deepak M, Amit A. 2004. The need for establishing identities of ‘bacoside A and B’, the putative major bioactive saponins of Indian medicinal plant Bacopa monnieri. Phytomedicine. 11(2–3):264–268. doi: 10.1078/0944-7113-00351.
   PubMed Web of Science ®Google Scholar
• Deng S, Tang Q, Duan X, Fan H, Zhang L, Zhu X, Hu J, Xu M, Chen Q, Liu Y, et al. 2019. Uncovering the anticancer mechanism of compound sophorae decoction against ulcerative colitis-related colorectal cancer in mice. Evid Based Complement Alternat Med. 2019:8128170. Oct 20oi: doi: 10.1155/2019/8128170.
   PubMed Web of Science ®Google Scholar
• Dubey T, Chinnathambi S. 2019. Brahmi (Bacopa monnieri): an ayurvedic herb against the Alzheimer’s disease. Arch Biochem Biophys. 676:108153. doi: 10.1016/j.abb.2019.108153.
   PubMed Web of Science ®Google Scholar
• D’Souza P, Deepak M, Rani P, Kadamboor S, Mathew A, Chandrashekar AP, Agarwal A. 2002. Brine shrimp lethality assay of Bacopa monnieri. Phytother Res. 16(2):197–198. doi: 10.1002/ptr.1001.
   PubMed Web of Science ®Google Scholar
• Goel RK, Sairam K, Babu MD, Tavares IA, Raman A. 2003. In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. Phytomedicine. 10(6–7):523–527. doi: 10.1078/094471103322331494.
   PubMed Web of Science ®Google Scholar
• Kamkaew N, Paracha TU, Ingkaninan K, Waranuch N, Chootip K. 2019. Vasodilatory effects and mechanisms of action of Bacopa monnieri active compounds on rat mesenteric arteries. Molecules. 24(12):2243. doi: 10.3390/molecules24122243.
   PubMed Web of Science ®Google Scholar
• Krawisz JE, Sharon P, Stenson WF. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 87(6):1344–1350. doi: 10.1016/0016-5085(84)90202-6.
   PubMed Web of Science ®Google Scholar
• Macaluso FS, Maida M, Renna S, Orlando E, Affronti M, Sapienza C, Dimarco M, Orlando R, Rizzuto G, Cottone M, et al. 2017. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants. Dig Liver Dis. 49(2):157–162. doi: 10.1016/j.dld.2016.10.001.
   PubMedGoogle Scholar
• Mallick MN, Khan W, Parveen R, Ahmad S, Sadaf, Najm MZ, Ahmad I, Husain SA. 2017. Exploring the cytotoxic potential of triterpenoids-enriched fraction of Bacopa monnieri by implementing in vitro, in vivo, and in silico approaches. Pharmacogn Mag. 13(Suppl 3):S595–S606. doi: 10.4103/pm.pm_397_16.
   PubMedGoogle Scholar
• Mathew J, Soman S, Sadanandan J, Paulose CS. 2010. Decreased GABA receptor in the striatum and spatial recognition memory deficit in epileptic rats: effect of Bacopa monnieri and bacoside-A. J Ethnopharmacol. 130(2):255–261. doi: 10.1016/j.jep.2010.04.043.
   PubMed Web of Science ®Google Scholar
• Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panetta J, Morris CJ, Blake DR. 1996. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 39(3):407–415. doi: 10.1136/gut.39.3.407.
   PubMed Web of Science ®Google Scholar
• Nemetchek MD, Stierle AA, Stierle DB, Lurie DI. 2017. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J Ethnopharmacol. 197:92–100. doi: 10.1016/j.jep.2016.07.073.
   PubMed Web of Science ®Google Scholar
• Nauseef WM. 2018. Biosynthesis of human myeloperoxidase. Arch Biochem Biophys. 642:1–9. doi: 10.1016/j.abb.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Palethorpe HM, Smith E, Tomita Y, Nakhjavani M, Yool AJ, Price TJ, Young JP, Townsend AR, Hardingham JE. 2019. Bacopasides I and II act in synergy to inhibit the growth, migration and invasion of breast cancer cell lines. Molecules. 24(19):3539. doi: 10.3390/molecules24193539.
   PubMed Web of Science ®Google Scholar
• Pei JV, Kourghi M, De Ieso ML, Campbell EM, Dorward HS, Hardingham JE, Yool AJ. 2016. Differential inhibition of water and ion channel activities of mammalian aquaporin-1 by two structurally related bacopaside compounds derived from the medicinal plant Bacopa ­monnieri. Mol Pharmacol. 90(4):496–507. doi: 10.1124/mol.116.105882.
   PubMed Web of Science ®Google Scholar
• Randhawa PK, Singh K, Singh N, Jaggi AS. 2014. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 18(4):279–288. doi: 10.4196/kjpp.2014.18.4.279.
   PubMed Web of Science ®Google Scholar
• Raish M, Ahmad A, Ansari MA, Alkharfy KM, Aljenoobi FI, Jan BL, Al-Mohizea AM, Khan A, Ali N. 2018. Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition. Int J Biol Macromol. 111:193–199. doi: 10.1016/j.ijbiomac.2018.01.008.
   PubMed Web of Science ®Google Scholar
• Rastogi M, Ojha RP, Devi BP, Aggarwal A, Agrawal A, Dubey GP. 2012. Amelioration of age associated neuroinflammation on long term bacosides treatment. Neurochem Res. 37(4):869–874. Epub 2011 Dec 25. PMID: 22198697. doi: 10.1007/s11064-011-0681-1.
   PubMed Web of Science ®Google Scholar
• Sabina EP, Peter S J, S P, Geetha A. 2019. A comparison of hepatoprotective activity of bacoside to silymarin treatment against a combined isoniazid and rifampin-induced hepatotoxicity in female Wistar rats. J Histotechnol. 42(3):128–136. doi: 10.1080/01478885.2019.1638535.
   PubMed Web of Science ®Google Scholar
• Saha S, Mahapatra KK, Mishra SR, Mallick S, Negi VD, Sarangi I, Patil S, Patra SK, Bhutia SK. 2020. Bacopa monnieri inhibits apoptosis and senescence through mitophagy in human astrocytes. Food Chem Toxicol. 141:111367. doi: 10.1016/j.fct.2020.11136.
   PubMed Web of Science ®Google Scholar
• Saini N, Singh D, Sandhir R. 2019. Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action. Metab Brain Dis. 34(2):505–518. doi: 10.1007/s11011-018-0332-1.
   PubMed Web of Science ®Google Scholar
• Sairam K, Rao CV, Babu MD, Goel RK. 2001. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine. 8(6):423–430. doi: 10.1078/S0944-7113(04)70060-4.
   PubMed Web of Science ®Google Scholar
• Sekhar VC, Viswanathan G, Baby S. 2019. Insights into the molecular aspects of neuroprotective bacoside A and bacopaside I. Curr Neuropharmacol. 17(5):438–446. doi: 10.2174/1570159X16666180419123022.
   PubMed Web of Science ®Google Scholar
• Simeoli R, Mattace Raso G, Pirozzi C, Lama A, Santoro A, Russo R, Montero-Melendez T, Berni Canani R, Calignano A, Perretti M, et al. 2017. An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis. Br J Pharmacol. 174(11):1484–1496. doi: 10.1111/bph.13637.
   PubMed Web of Science ®Google Scholar
• Smith E, Palethorpe HM, Tomita Y, Pei JV, Townsend AR, Price TJ, Young JP, Yool AJ, Hardingham JE. 2018. The purified extract from the medicinal plant Bacopa monnieri, bacopaside II, inhibits growth of colon cancer cells in vitro by inducing cell cycle arrest and apoptosis cells. Cells. 7(7):81. doi: 10.3390/cells7070081.
   PubMed Web of Science ®Google Scholar
• Shamah S, Schneider J, Korelitz BI. 2018. High incidence of recurrent Crohn’s disease following colectomy for ulcerative colitis revealed with long follow-up. Dig Dis Sci. 63(2):446–451. doi: 10.1007/s10620-017-4873-7.
   PubMed Web of Science ®Google Scholar
• Shinomol GK, Bharath M, Muralidhara MS. 2011. Exploring the role of “Brahmi” (Bacopa ­monnieri and Centella asiatica) in brain function and therapy. Recent Pat Endocr Metab Immune Drug Discov. 5(1):33–49. doi: 10.2174/187221411794351833.
   PubMedGoogle Scholar
• Sukumaran NP, Amalraj A, Gopi S. 2019. Neuropharmacological and cognitive effects of Bacopa monnieri (L.) Wettst – a review on its mechanistic aspects. Complement Ther Med. 44:68–82. doi: 10.1016/j.ctim.2019.03.016.
   PubMed Web of Science ®Google Scholar
• Ungaro F, D’Alessio S, Danese S. 2020. The role of pro-resolving lipid mediators in colorectal cancer-associated inflammation: implications for therapeutic strategies. Cancers. 12(8):2060. doi: 10.3390/cancers12082060.
   PubMed Web of Science ®Google Scholar
• Walia D, Kaur G, Jaggi A, Bali A. 2019. Exploring the therapeutic potential of sodium benzoate in acetic acid-induced ulcerative colitis in rats. Journal of Basic and Clinical Physiology and Pharmacology. 30(5):20190086. doi: 10.1515/jbcpp-2019-0086.
   Google Scholar
• Wallace JL, MacNaughton WK, Morris GP, Beck PL. 1989. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 96(1):29–36. doi: 10.1016/0016-5085(89)90760-9.
   PubMed Web of Science ®Google Scholar
• Zatorski H, Sałaga M, Zielińska M, Piechota-Polańczyk A, Owczarek K, Kordek R, Lewandowska U, Chen C, Fichna J. 2015. Experimental colitis in mice is attenuated by topical administration of chlorogenic acid. Naunyn Schmiedebergs Arch Pharmacol. 388(6):643–651. doi: 10.1007/s00210-015-1110-9.
   PubMed Web of Science ®Google Scholar